Research News - September 11, 2020

 

  F Youtube T IN
 
September 11, 2020
ANNOUNCEMENTS
 

1. 2020 MGRI Image Contest is Now Open
2. Annual ECOR Elections - Nominations are Open!
3. NIH Update: Free Virtual NIH Funding Seminar, Award Rates and Funding Disparities, New Annotated Forms
4. Request your CentOS Upgrade for ERIS DIPR Hosted Linux Virtual Servers by November 30, 2020

EVENTS
 

1. MGH Celebration of Science 2020
2. Join the Virtual Research Technical Talk
3. Virtual Nursing Research Day

FUNDING OPPORTUNITIES
 

1. COVID Funding Opportunities
2. NCI Outstanding Investigator Award (R35)
3. B-BIC & RADX-RAD Funding Opportunity
4. Applied Research Fellowship in Healthcare Innovation
5. 2021 Bullock Postdoctoral Fellowship
6. HMS Foundation Funds
7. Damon Runyon Clinical Investigator Award
8. Limited Submission Funding Opportunities
9. Foundation Funding Opportunities

In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events
 
ANNOUNCEMENTS
 
1. 2020 MGRI Image Contest is Now Open

The MGRI Image Contest provides an opportunity for scientists to share their best research images, stories and unique points of view with colleagues and science fans across the globe. Plus who doesn't love a little friendly competition?

We want to see what research means to you. We will accept any research-related images, including but not limited to: Microscope/lab images, scans, 3-D models, team photos and more! Researchers can enter a maximum of three images between now and September 25.

 
2. Annual ECOR Elections - Nominations are Open!

Nominate Yourself or a Colleague!

Nominations Deadline: Friday, September 11

- TWO OPENINGS -
One Associate Professor
One Professor

For information about ECOR & ECOR Reps responsibilities go to: http://ecor.mgh.harvard.edu/about/elections

Nomination form: https://ecor.mgh.harvard.edu/elections/NominationForm.aspx

Questions? ECOR@mgh.harvard.edu

 
3. NIH Update: Free Virtual NIH Funding Seminar, Award Rates and Funding Disparities, New Annotated Forms

Click here to read the latest news from the NIH.

 
4. Request your CentOS Upgrade for ERIS DIPR Hosted Linux Virtual Servers by November 30, 2020

All CentOS 6 Virtual Machines (VMs) will reach End of Life on November 30th, 2020. End of Life means the product is no longer supported by Red Hat and the community-supported CentOS distribution for Red Hat Enterprise Linux. The ERIS team will not support CentOS 6 VMs after November 30th, 2020, as there will be no security updates and bug fixes for CentOS 6. All applications and websites running on CentOS 6 VMs must migrate to new CentOS 8 VMs before November 30th, 2020. Please upgrade by requesting a new DIPR VM in the ERIS Research Computing Core Service Catalog. Contact us at rcc@partners.org with any questions.

 
Back to top
EVENTS
 
1. MGH Celebration of Science 2020

Monday, September 21, 2:00 - 4:00 pm, Attend via Zoom

2:00 - 2:30 PM 
Welcome
Peter L. Slavin, MD, President, Massachusetts General Hospital
                                        
Opening Comments   
David E. Fisher, MD, PhD, Chair, Executive Committee on Research (ECOR) 

Introduction of the 2020 Claflin Distinguished Scholar Awards & MGH Physician Scientist Development Awards
David E. Fisher, MD, PhD, Chair, Executive Committee on Research (ECOR) 

Introduction of the Anne Klibanski Visiting Scholar Awards
Miriam A. Bredella, MD, Director, Center for Faculty Development

2:30 - 2:45 PM 
Introduction of the Class of 2020 MGH Research Scholars and new MGRI Chairs 
Susan A. Slaugenhaupt, PhD, Scientific Director, MassGeneral Research Institute

2:45 - 3:10 PM 
2020 Goodman Award
Immunity to Commensal Papillomaviruses for Cancer Prevention

Shawn Demehri, MD, PhD
Assistant Professor of Dermatology, Harvard Medical School; Investigator, Center for Cancer Immunology & Cutaneous Biology Research Center, Massachusetts General Hospital

3:10 - 3:35 PM 
2020 Martin Prize for Clinical Research 
Exercise Reduces Inflammatory Cell Production and Cardiovascular Inflammation via Instruction of Hematopoietic Progenitor Cells

Matthias Nahrendorf, MD, PhD
Richard Moerschner Endowed MGH Research Institute Chair in Men's Health, Weissman Family MGH Research Scholar 2014-2019; Professor of Radiology, Harvard Medical School; Investigator, Center for Systems Biology, Massachusetts General Hospital 

3:35 - 4:00 PM 
2020 Martin Prize for Fundamental Research
Targeting the CBM Complex Causes Treg Cells to Prime Tumors for Immune Checkpoint Therapy

Thorsten Mempel, MD, PhD
Bob and Laura Reynolds MGH Research Scholar 2014-2019; Associate Professor of Medicine, Harvard Medical School; Associate Investigator, Center for Immunology and Inflammatory Diseases & Rheumatology, Allergy & Immunology, Massachusetts General Hospital

 
2. Join the Virtual Research Technical Talk

Thursday, September 24 from 12-2p.m., MS Teams

This month features An Overview of Enterprise Delivery Services (EDS): Deep Dive of Disaster Recovery, Active Directory, Application Delivery, Databases & Printing provided by Herb Harrison and team. We will also hear from the IS Support Services team with information about InfoBot, Purchasing Hardware and other IS Support-related topics. This monthly meeting is geared for research IT administrators and managers who support research and innovation departments but is open to anyone in the Mass General Brigham community. Subscribe to receive the monthly meeting invite if you’re interested in learning more or attending.

 
3. Virtual Nursing Research Day

We are excited to share with you that the Munn Center will host a Virtual Nursing Research Day comprised of the annual Nursing Research Lecture and Presentation of Awards (Munn Nursing Research Awards and Poster Awards) as well as a Virtual Poster Showcase. This event will take place on Tuesday, October 6th, from 1:30 - 3 pm and details including registration, the link to the Virtual Poster Showcase, and the WebEx are forthcoming.

We are excited to showcase 58 posters- the largest number to date!- that demonstrate the incredible work of MGH nurses in Evidence Based Practice, Original Research, and Quality Improvement. We will also recognize 3 extraordinary nurse and mentor recipients of the Munn Nursing Research Awards.

The title of this year’s lecture is:
“The Gifts of the Hero’s Journey: Revealing the Extraordinary in
Ordinary Nursing Practice”

Presented by: Marlaine C. Smith, RN, PhD, AHN-BC, HWNC-BC, FAAN
Professor and Helen K. Persson Eminent Scholar
Christine E. Lynn College of Nursing
Florida Atlantic University

Please Save the Date and share it with your colleagues!

We hope you are able to join us. Please contact munncenter@partners.org with any questions.

 
Back to top
FUNDING OPPORTUNITIES
 
1. COVID Funding Opportunities

Please visit the new MGB web page for COVID funding opportunities that provides a central database for researchers to view open and competitive funding announcements.

We have aggregated opportunities from federal and private funding sources including NIH, DoD, CDC, EPA, foundations, and more.  The database defaults to sorting by award amount and can also be sorted by deadline or filtered by research focus.

Upcoming deadlines: 

Recently added:

 
2. NCI Outstanding Investigator Award (R35)

The National Cancer Institute (NCI) recently announced the 2020 Outstanding Investigator Award (OIA) funding opportunity announcement: PAR-20-278. The objective of the NCI Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. 

The OIA will support investigators with outstanding records of productivity in cancer research with up to $600,000 in direct costs per year for up to seven years.

It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.

Applicants are required to devote at least 6 person months effort to the OIA. The Institution will be expected to provide clear and continuing substantial commitment to the PD/PI, including a commitment of at least 20 percent salary support.

Although MGH may submit more than one application to this program, provided each is scientifically distinct, an institutional review and a letter of nomination are required for applicants to this funding opportunity. 

How to Apply

Anyone interested in applying to this program must submit a 1-2 Letter of Intent and a biosketch to ecor@mgh.harvard.edu by Monday, September 21, 2020 at 5:00 pm

The letter of intent should include:

  1. Name of the Principal Investigator with appropriate contact information
  2. A descriptive title of the potential application
  3. Brief description of the project
  4. A description of why the applicant should be nominated for this opportunity
 
3. B-BIC & RADX-RAD Funding Opportunity

We have been asked by the NIH and NHLBI to assist in soliciting technology development proposals in response to the declared public health emergency issued by the Secretary, Department of Health and Human Services (DHHS), for the 2019 Novel Coronavirus (COVID-19) under the Rapid Acceleration of Diagnostics - Radical (RADx-rad) program. Specifically, the NIH has published three Requests for Proposals (RFAs) that support the development of technologies for “Novel Biosensing for Screening, Diagnosis, and Monitoring of COVID-19 from Skin and the Oral Cavity”.

While the three NIH RFAs call for relatively advanced projects, this RADx-rad biosensing initiative aims to support incubation of promising early stage projects solicited through B-BIC to advance early Feasibility and Proof of Concept work (analogous to Phase I SBIR projects).

More information about the opportunity can be found here:  https://www.bbicradx.com/

All interested applicants will need to register for a Fast Pitch with us no later than September 10th.  
Invitations to apply for the opportunity will only be extended to investigators after a successful Fast Pitch. Details for registering for a Fast Pitch are on the opportunity website.  

If invited, full proposals must be submitted with Institutional Authorization no later than October 8th.

If anyone has any questions about the opportunity, please reach out to Lesley Watts (lwatts@bics.bwh.harvard.edu).
 
4. Applied Research Fellowship in Healthcare Innovation

Applications for the 2021-2022 MGH HTL Applied Research Fellowship in Healthcare Innovation are now open–with a submission deadline of Sept 30, 2020.

The MGH Healthcare Transformation Lab (HTL) is currently seeking applications for our one-year Applied Research Fellowship in Healthcare Innovation. HTL’s founding mission is to improve the experience and value of healthcare through collaborative innovation. The fellowship program (now in its fourth year) provides a unique opportunity for physicians to have protected time to develop and engage in care delivery transformation projects at MGH with mentorship from experts in the field as well as support from senior leadership. Using principles of innovation science and leveraging new technologies, fellows are encouraged to pursue projects that enhance the delivery of healthcare—making it a better experience for patients/clinicians and potentially more affordable and/or higher-value.

For more information, please visit http://healthcaretransformation.org/fellowship/.

 
5. 2021 Bullock Postdoctoral Fellowship

Applications are being accepted for the 2021 Bullock Postdoctoral Fellowship.
Proposal deadline:  5:00 pm – November 2, 2020  
Award decision:  December 21,  2020

Potential candidate must be at the postdoctoral training level at the time of the award. PhD, MD and MD/PhD research fellows are eligible for this award. Criteria for funding are scientific quality, enabling collaboration that might not occur otherwise, potential medical and scientific impact, and career development of the Fellow. 

Combined mentorship and collaboration between two Harvard Medical School faculty members, at least one of whom is based at the Wellman Center for Photomedicine, is required. An external collaborator is preferred. It is anticipated that the fellow will perform the majority of their research at the Wellman Center.
The Fellowship will provide one year of support. An award of up to $60,000 direct costs is anticipated. The award will be administered by the Wellman Center. Funds may be used for stipend (minimum effort 60%), fringe benefits and research supplies.  

The fellowship will begin on or about January 1, 2021 and is intended for one year.  The fellowship review committee will consider a one-time 6 month no cost extension (maximum project duration, 18 consecutive months).Any remaining funds at the end of the award period will be forfeited.   

For additional information and instructions regarding the application process please refer to this announcement: BullockFellowshipAward

 
6. HMS Foundation Funds

Each year several foundations invite HMS faculty and postdocs to apply for their fellowships and grants, which serve as critical funding at the early stages of a research career.  Interested investigators must first apply for the HMS nomination through the HMS Foundation Funds office, and a committee will select the final candidates to submit applications to the sponsors. 

Awards include:

  • Brain Research Foundation Fay/Frank Seed Grant Program
  • Macy Foundation Faculty Scholars Program
  • Edward Mallinckrodt Jr. Scholars Award
  • Mary Kay Innovative/Translational Cancer Research Award
  • Packard Foundation Fellowship in Science and Engineering

Faculty and postdocs interested in applying for any of the awards listed above can apply for the HMS nomination by submitting an application online no later than Monday, October 19, 2020 at 11:30 PM. For information on application guidelines, click here.

For some awards, MGH receives invitations to submit their own nominations. In this case, MGH faculty must first apply for the MGH nomination through ECOR and a committee at MGH will select the final MGH candidate(s) to submit applications to the foundations. Click here to view a chart of the current opportunities and the Institution that MGH faculty should apply through. Internal announcements are forthcoming for the following opportunities in which MGH is invited to submit their own application:

  • Damon Runyon Clinical Investigator Award
  • Smith Family Foundation: Odyssey Award


Please direct all inquiries regarding the application process at HMS to Clare Lamont, Program Coordinator, Office for Academic and Clinical Affairs, 617-432-7463, clare_lamont@hms.harvard.edu.  If you have questions regarding the MGH application process, please email MGH ECOR, ecor@mgh.harvard.edu

 
7. Damon Runyon Clinical Investigator Award

Intended to support independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. ECOR is now accepting letters of intent.

Letter of intent deadline: Tuesday, November 10, 2020 - 5:00 PM
Faculty Type: Independent Assistant Professors who hold an MD or MD/PhD
Award Amount: $600,000 for a period of three years
Submit letter of intent and biosketch to ecor@mgh.harvard.edu      

Click here to view the requirements for the 1-2 page letter of intent
Click here to visit the Damon Runyon Cancer Research Foundation website

 
8. Limited Submission Funding Opportunities

We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.

Process
Submit a one- to two-page Letter of Intent (LOI) to the MGH Executive Committee on Research (ECOR) via email to ecor@partners.org.  In addition to your LOI, please include an NIH Biosketch.

The letter of intent should include:

  • Name of the Principal Investigator with appropriate contact information
  • A descriptive title of the potential application
  • Brief description of the project
  • Brief description of why you specifically should be selected to receive institutional nomination for this award


If there is more than one MGH investigator interested in applying for each limited submission award, the LOIs will be used to assess candidates and a review and selection process will take place.

Current Limited Submission Funding Opportunities
Please click here for more information and for our internal deadlines.

  • Livestrong Solution Grants – Acceleration and Transformation Grants
  • Collaborative Centers in Children’s Environmental Health Research and Translation (P2C Clinical Trial Optional)
  • Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required)
  • Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)
  • NIOSH Centers of Excellence for Total Worker Health (U19)
  • Martin Delaney Collaboratories for HIV Cure Research (UM1 Clinical Trial Not Allowed) and Martin Delaney Collaboratory for Pediatric HIV Cure Research (UM1 Clinical Trial Not Allowed)
  • Clinical and Translational Science Award (U54 - Clinical Trial Optional) – NEW!
  • NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)

If there is a limited submission funding opportunity you do not see listed above or you have any additional questions, please let us know at ecor@mgh.harvard.edu.

 
9. Foundation Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities.  Note that proposals are still routed through the standard Insight/Research Management process.

Please be aware that any grant that brings in less than 15% in indirect costs (IDC) will need to be supplemented up to the 15% equivalent by existing investigator or departmental sundry funds. Resolution of this issue must occur prior to submitting a proposal.  Training fellowships from foundations, public charity, and non-profit organizations are excluded from this minimum IDC requirement.

Week of 9/11/20

  •  Sheila Essey Award: An Award for ALS Research ($50,000), American Academy of Neurology (AAN)
  • Research Awards: Bridge Award ($100,000), American Association for the Study of Liver Diseases (AASLD)
  • Research Scholar Awards ($80,000), American Urological Association (AUA)/Urology Care Foundation
  • Clinic and Laboratory Integration Program (CLIP) Grants ($200,000), Cancer Research Institute (CRI)
  • Technology Impact Award ($200,000), Cancer Research Institute (CRI)
  • The COVID-19 Symptom Data Challenge ($55,000), Facebook NEW! COVID!
  • Research Grants ($75,000), Foundation for Women's Cancer (FWC)
  • Postdoctoral Fellowship ($160,500), Hope Funds for Cancer Research
  • Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Alopecia Areata ($250,000), Pfizer Global Medical Grants (GMG) NEW!
  • PARP-inhibitor Combination Treatments in Prostate Cancer ($250,000), Pfizer Global Medical Grants (GMG) NEW!
  • Remote Mentoring Programs in Renal Cell Carcinoma (RCC) ($200,000), Pfizer Global Medical Grants (GMG) NEW!
 
Back to top
In Case You Missed It
 
Reminders of recently posted funding opportunities, deadlines and events

Check out the Coronavirus Resource Guide for MGH Researchers!

NIH Update for Week Ending September 11, 2020

BIRCWH (Building Interdisciplinary Research Careers in Women's Health)
Application Deadline: September 15, 2020

PCORI - Click here for the latest funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI).

Looking for something you saw in a previous Research News release? Check out our archive!

Back to top
 
RESOURCES  

ECOR Website

Mass General Research Institute

MGH Research Intranet

Research Help and How-To

 

Click here to subscribe to MGH Research Email announcements.
Executive Committee On Research (ECOR) Massachusetts General Hospital
125 Nashua Street, Suite 822, Boston, MA 02114
ecor@mgh.harvard.edu